Search Results - "ROWLAND, L. P"

Study of 962 patients indicates progressive muscular atrophy is a form of ALS by KIM, W.-K, LIU, X, SANDNER, J, PASMANTIER, M, ANDREWS, J, ROWLAND, L. P, MITSUMOTO, H

“…Progressive muscular atrophy (PMA) is clinically characterized by signs of lower motor neuron dysfunction and may evolve into amyotrophic lateral sclerosis…”
Get full text

The natural history of primary lateral sclerosis by GORDON, P. H, CHENG, B, KATZ, I. B, PINTO, M, HAYS, A. P, MITSUMOTO, H, ROWLAND, L. P

“…To define the syndrome of primary lateral sclerosis (PLS) and disorders that contain features of both ALS and PLS, to determine the time beyond which PLS is…”
Get full text

The ALSFRSr predicts survival time in an ALS clinic population by KAUFMANN, P, LEVY, G, THOMPSON, J. L. P, DELBENE, M. L, BATTISTA, V, GORDON, P. H, ROWLAND, L. P, LEVIN, B, MITSUMOTO, H

“…To determine whether the Amyotrophic Lateral Sclerosis Functional Rating Scale-revised (ALSFRSr), a predictor of survival time in ALS clinical trials, predicts…”
Get full text

Quantitative objective markers for upper and lower motor neuron dysfunction in ALS by MITSUMOTO, H, ULUG, A. M, MONTES, J, HAYES, S, DASHNAW, S, KAUFMANN, P, GORDON, P. H, HIRSCH, J, LEVIN, B, ROWLAND, L. P, SHUNGU, D. C, PULLMAN, S. L, GOOCH, C. L, CHAN, S, TANG, M.-X, MAO, X, HAYS, A. P, FLOYD, A. G, BATTISTA, V

“…To investigate the value of objective biomarkers for upper (UMN) and lower (LMN) motor neuron involvement in ALS. We prospectively studied 64 patients with ALS…”
Get full text

Prevalence of depressive disorders and change over time in late-stage ALS by RABKIN, J. G, ALBERT, S. M, DEL BENE, M. L, O'SULLIVAN, I, TIDER, T, ROWLAND, L. P, MITSUMOTO, H

“…To determine the prevalence of depressive disorders and symptoms in patients with late-stage ALS, to identify possible risk and protective factors associated…”
Get full text

Premorbid weight, body mass, and varsity athletics in ALS by SCARMEAS, N, SHIH, T, STERN, Y, OTTMAN, R, ROWLAND, L. P

“…Several famous athletes have been affected by ALS, and some epidemiologic studies have indicated that vigorous physical activity (heavy labor or athletics) is…”
Get full text

Clinical features that distinguish PLS, upper motor neuron―dominant ALS, and typical ALS by GORDON, P. H, CHENG, B, KATZ, I. B, MITSUMOTO, H, ROWLAND, L. P

“…To determine how clinical features at the first evaluation and in follow-up can be used to suggest a diagnostic outcome for patients with only upper motor…”
Get full text

Wish to die in end-stage ALS by ALBERT, S. M, RABKIN, J. G, DEL BENE, M. L, TIDER, T, O'SULLIVAN, I, ROWLAND, L. P, MITSUMOTO, H

“…In retrospective studies, estimates of hastened dying among seriously ill patients range from <2% in one national survey to as much as 20% in end-stage disease…”
Get full text

Transcranial magnetic stimulation in ALS : Utility of central motor conduction tests by FLOYD, A. G, YU, Q. P, PIBOOLNURAK, P, TANG, M. X, FANG, Y, SMITH, W. A, YIM, J, ROWLAND, L. P, MITSUMOTO, H, PULLMAN, S. L

“…To investigate transcranial magnetic stimulation (TMS) measures as clinical correlates and longitudinal markers of amyotrophic lateral sclerosis (ALS). We…”
Get full text

Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS) by KAUFMANN, P, PULLMAN, S. L, SHUNGU, D. C, CHAN, S, HAYS, A. P, DEL BENE, M. L, DOVER, M. A, VUKIC, M, ROWLAND, L. P, MITSUMOTO, H

“…To develop objective markers for upper motor neuron (UMN) involvement in ALS, the value of single-voxel MR spectroscopy (MRS) and transcranial magnetic…”
Get full text

Randomized controlled phase II trial of glatiramer acetate in ALS by GORDON, P. H, DOORISH, C, GENDELMAN, H. E, PRZEDBORSKI, S, MITSUMOTO, H, MONTES, J, MOSELY, R. L, DIAMOND, B, MACARTHUR, R. B, WEIMER, L. H, KAUFMANN, P, HAYS, A. P, ROWLAND, L. P

“…The authors conducted a randomized controlled trial to test the safety and immunology of glatiramer acetate in ALS. Twenty treated patients were randomly…”
Get full text

Myasthenic crisis : Clinical features, mortality, complications, and risk factors for prolonged intubation by THOMAS, C. E, MAYER, S. A, GUNGOR, Y, SWARUP, R, WEBSTER, E. A, CHANG, I, BRANNAGAN, T. H, FINK, M. E, ROWLAND, L. P

“…We retrospectively reviewed the hospital records of 53 patients admitted for 73 episodes of myasthenic crisis at Columbia-Presbyterian Medical Center over a…”
Get full text

Challenges and opportunities in clinical trials for spinal muscular atrophy by HIRTZ, D, IANNACCONE, S, HEEMSKERK, J, GWINN-HARDY, K, MOXLEY, R. III, ROWLAND, L. P

“…Spinal muscular atrophy (SMA) is the most common fatal neuromuscular disease of infancy. SMA type I is the most severe and mortality is usually due to…”
Get full text

Inclusion body myositis and myopathies by Griggs, R C, Askanas, V, DiMauro, S, Engel, A, Karpati, G, Mendell, J R, Rowland, L P

Get more information

Diagnosis of amyotrophic lateral sclerosis by Rowland, Lewis P

“…This review of the differential diagnosis of amyotrophic lateral sclerosis focuses on two themes. The first is practical, how to establish the diagnosis based…”
Get full text

Mitochondrial neurogastrointestinal encephalomyopathy: An autosomal recessive disorder due to thymidine phosphorylase mutations by Nishino, Ichizo, Spinazzola, Antonella, Papadimitriou, Alexandros, Hammans, Simon, Steiner, Israel, Hahn, Cecil D., Connolly, Anne M., Verloes, Alain, Guimarães, João, Maillard, Ivan, Hamano, Hitoshi, Donati, M. Alice, Semrad, Carol E., Russell, James A., Andreu, Antonio L., Hadjigeorgiou, Giorgos M., Vu, Tuan H., Tadesse, Saba, Nygaard, Torbjoern G., Nonaka, Ikuya, Hirano, Ikuo, Bonilla, Eduardo, Rowland, Lewis P., DiMauro, Salvatore, Hirano, Michio

“…Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an autosomal recessive disorder defined clinically by severe gastrointestinal dysmotility;…”
Get full text

Impact of spirituality and religiousness on outcomes in patients with ALS by MURPHY, P. L, ALBERT, S. M, WEBER, C. M, DEL BENE, M. L, ROWLAND, L. P

“…The Project of Death in America Study at Columbia Presbyterian Medical Center enrolled 121 patients with ALS from 1996 through 1997, 46 of whom participated in…”
Get full text

A prospective study of preferences and actual treatment choices in ALS by ALBERT, S. M, MURPHY, P. L, DEL BENE, M. L, ROWLAND, L. P

“…To determine whether ALS patients' preferences for ameliorative or life-extending technologies elicited early in the disease were related to later treatment…”
Get full text

MELAS: clinical features, biochemistry, and molecular genetics by Ciafaloni, E, Ricci, E, Shanske, S, Moraes, C T, Silvestri, G, Hirano, M, Simonetti, S, Angelini, C, Donati, M A, Garcia, C

“…We studied 23 patients with clinically defined mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), 25 oligosymptomatic or…”
Get more information

Deletions of mitochondrial DNA in Kearns-Sayre syndrome by ZEVIANI, M, MORAES, C. T, DIMAURO, S, NAKASE, H, BONILLA, E, SCHON, E. A, ROWLAND, L. P

“…We have identified large-scale deletions in muscle mitochondrial DNA (mtDNA) in seven of seven patients with Kearns-Sayre syndrome (KSS). We found no…”
Get full text